TYRA 10-Q: SEC filing

Tyra Biosciences

Filed with the SEC on Nov 10, 2026 · accession 0001193125-26-454481

TYRA filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -1.3% by the first close after the filing.

Summary of the filing

Tyra Biosciences filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial results and pipeline updates for its clinical-stage oncology programs including dabogratinib.

For details, click here →How to read a 10-Q →

Key details

FilerTyra Biosciences, Inc.

How TYRA stock reacted

Close before

$22.30

Nov 9, 2026

First close after

-1.26%

$22.02

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for TYRA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TYRA?

Click here

Frequently asked questions

What did TYRA file with the SEC on Nov 10, 2026?

TYRA filed a 10-Q (SEC filing). Tyra Biosciences filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial results and pipeline updates for its clinical-stage oncology programs including dabogratinib.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did TYRA stock react to this filing?

TYRA closed at $22.30 before the filing and $22.02 on Nov 10, 2026 (-1.26%).

Other TYRA SEC filings

Get alerts when TYRA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

TYRA overview TYRA analysis TYRA news Latest SEC filings